John Wm Martens

68PUBLICATIONS
359CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Instrumental methods (excl. immunological and bioassay methods)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|May 04, 2026
Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer.

|Feb 12, 2026
Identification of Resistance Genes in Breast Cancer Cells Treated with Fulvestrant and Ribociclib via Retroviral Screening and Integration Site Sequencing.

Zhangzan Huang, Corine Beaufort, Jean Helmijr

|Sep 04, 2025
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial.

Elisabeth M Jongbloed, Noor Wortelboer, Vanja de Weerd

|Jul 31, 2025
PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients.

Eshwari Dathathri, Fikri Abali, Michiel Stevens

|Mar 14, 2025
Cell-free DNA aneuploidy score as a dynamic early response marker in prostate cancer.

Khrystany T Isebia, Anouk C de Jong, Lisanne F van Dessel

|Aug 22, 2024
TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer.

Dian Kortleve, Dora Hammerl, Mandy van Brakel

Pageof 12

Frequent Collaborators

13 joint publications

Saskia Wilting

9 joint publications

Martijn P Lolkema

8 joint publications

Jaco Kraan

8 joint publications

Marcel Smid